PROGRAM
DAY ONE: Friday 9th May 2014
​8:30
Openning Session
​11:00
Coffee Break
​9:00
Conference#1: Innovative Therapeutic Approaches, Industrial Challenges - Part 1
Chairman: Rémi Urbain, LFB Biotechnologies
Cell Therapy: Industrial Challenges, Sébastien Renouf - LFB CELLforCURE
Industrialization of a stem cell process, how to identify the right strategy? Fabien Moncaubeig - ATMI LIFE SCIENCE - PALL
Antibody Drug Conjugate Design and Development, Véronique Blanc – SANOFI
​10:30 Coffee Break
​11:00
Conference#1: Innovative Therapeutic Approaches, Industrial Challenges - Part 2
Chairman: Bertrand Garbay, ENSTBB
New Challenges in Gene Therapy: Development of a lentiglobine vector, Olivier Negre - BLUEBIRD BIO
Industrialization of Gene Therapy, Mathias Hebben - GENETHON
Synthetic Biology for Small Molecules of Pharmaceutical Interest: artemisinine and hydrocortisone, Anne-Sophie Coquel - SANOFI
​12:30
Lunch Break
​14:00
Round Table: A Journey in Biotech Entrepreneurship: Experiences and Feedback.
Chairman: Gary BRANDAM, BIOTEM
Participants:
Gabriel Festoc, President at POLYPLUS-TRANSFECTION SA, Co-Founder at BAOLABS and strategic consultant for biotech companies and investors
Bertrand Coissac, Founder and Managing Director at ASIA BIO CHANNEL, Co-Founder and CEO at BAOLABS
Zaki Sellam, Strategic Business Development & Operations at CARBOMIMETICS & Independant Biotech Consultant
​15:00
Conference#2: New Trends in Quality Management & Regulatory Affairs
Chairwoman: Brigitte Lindet, ENSTBB
Virus safety layered strategy in biopharmaceutical processing, Cédric Geyer - MERCK MILLIPORE
Knowledge Management of Quality Systems in Biopharmaceuticals Industries, Yvan Gouttebelle - THE BIOTECH QUALITY GROUP
Paradigm shift in Toxicology: What are the new trends in USA from the FDA's and the US EPA's point of view and the European counterpart, François Busquet, JOHNS HOPKINS UNIVERSITY - CAAT
​16:30 Coffee Break
​17:00
Conference#3: Company & Technology Presentations
MaSTherCell, Patrick Stragier, Chief Business & Technology Officer
BIOTECH DEVA, Céline Thizon, Project Manager
STALLERGENES, Vincent Lombardi, Head of Immunomonitoring
PALL FORTEBIO, Yasmine Zouicha
​18:30
Networking Session
DAY TWO: Saturday 10th May 2014
​9:00
Openning Session
​9:30
Conference#4: New Trends in Biomanufacturing
Chairman: Xavier Santarelli, ENSTBB
​10:30
Coffee Break
Mabs Continuous Production, Steven Strubbe - MERCK BIODEVELOPMENT
An integrated Assessment of High Processing and Administration for a Therapeutic mAb, Nicolas Fouque - NOVIMMUNE
A New Benchmark for Single Use Cell Culture Harvesting, Jerome Pezzini, SARTORIUS STEDIM BIOTECH
​11:00
Round Table: Job Opportunity
​12:00
Closing Session